a public good project by the
Synthesis
Company
of California

© 2026

Tu‐Hsueh Yeh | doi.page

0 works0 citations0 h-index

Tu‐Hsueh Yeh

Taipei Medical University Hospital(TW)Taipei Medical University(TW)

Publications by Year

Research Areas

Parkinson's Disease Mechanisms and Treatments, Neurological diseases and metabolism, Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Nuclear Receptors and Signaling

Most-Cited Works

→ Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study(2012)1,213 cited
→ Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation(2008)181 cited
→ LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study(2018)160 cited
→ Preclinical Cancer Therapy in a Mouse Model of Neurofibromatosis-1 Optic Glioma(2008)136 cited
→ Immunohistochemical Analysis Supports a Role for INI1/SMARCB1 in Hereditary Forms of Schwannomas, but Not in Solitary, Sporadic Schwannomas(2008)133 cited
→ PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons(2011)120 cited

→ Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)‐regulated glial proliferation(2009)120 cited

→ High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas(2008)107 cited

→ Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL(2005)95 cited

→ HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3(2010)95 cited